Published in Cancer Weekly, February 11th, 2003
"There is mounting evidence that hematological malignancies are increased in systemic lupus erythematosus, and the risk of certain solid tumors may also be increased," said Sasha Bernatsky and colleagues at Montreal General Hospital and McGill University in Montreal, Canada.
"The pathogenesis may be different for the two processes: risk of hematological malignancies in SLE may be due to chronic lymphocyte stimulation, while...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2003-02-11)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.